Allogenic stem cell in diabetic wound

Phase 1

Recruiting

• Conditions: Chronic diabetic foot Ulcer.; Type 2 diabetes mellitus with foot ulcer; E11.621

• Registration Number: IRCT20170612034485N2
• Lead Sponsor: Iranian academic center for education culture and research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Chronic neuropathic diabetic foot ulcer (more than 6 weeks) with wound classification Wagner II
full informed consent for recruitment in the study
Suitable tissue perfusion (ABI>0.8) and normal flow of main arteries in lower extremities

Exclusion Criteria

Suspected osteomyelitis
Using corticosteroid or immuno-suppressor drug
Chronic renal failure of Hemodialysis
Charco Joint

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ocal and systemic side-effects. Timepoint: Every month up to month 6th. Method of measurement: Clinical examination.;Complete wound healing during study (at least 6 months). Timepoint: Every month up to month 6th. Method of measurement: Clinical examination.